-
UTI Healthcare IDCW-P
Equity healthcare
Overview ( as on 26/12/25 )
NAV
₹219.57
Last change
₹-0.96 -0.0%
Fund Size (AUM)
1126.13 Cr
Performance
14.78% (5Y)
Fund Details
UTI Healthcare IDCW-P
as of 26/12/25
AUM
1126.13 Cr
Expense Ratio
2.26 %
Benchmark
BSE Healthcare TR INR
ISIN
INF789F01679
Fund Manager
Kamal Gada
Exit Load
1.0% if redeemed within 0-30 days
0% if redeemed after 30 days
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| UTI Healthcare IDCW-P | -1.31% | 24.1% | 14.78% |
| BSE Healthcare TR INR | 2.79% | 23.3% | 17.18% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
9.76% |
Ajanta Pharma Ltd |
6.48% |
Lupin Ltd |
5.91% |
Glenmark Pharmaceuticals Ltd |
4.06% |
Dr Reddy's Laboratories Ltd |
3.74% |
Gland Pharma Ltd |
3.46% |
Apollo Hospitals Enterprise Ltd |
3.45% |
Alkem Laboratories Ltd |
3.43% |
Procter & Gamble Health Ltd |
3.41% |
Cipla Ltd |
3.4% |
Sector Allocation
Healthcare |
98.95% |
Basic Materials |
1.05% |
Asset Allocation
-
99%
Equity
-
1%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Growth
Equity healthcare-
Returns
-
17.65% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
16.98% (5Y)
-
-
UTI Healthcare Growth
Equity healthcare-
Returns
-
14.78% (5Y)
-
-
UTI Healthcare IDCW-P
Equity healthcare-
Returns
-
14.78% (5Y)
-
-
UTI Healthcare IDCW-R
Equity healthcare-
Returns
-
14.78% (5Y)
-
-
SBI Healthcare Opportunities Growth
Equity healthcare-
Returns
-
16.52% (5Y)
-
